Search from website

mAb to Influenza A, clone 8F8

mAb to Influenza A, clone 8F8  

Figure 1.  Simply Blue stained SDS-PAGE analysis of Monoclonal antibody to Influenza A, clone 8F8. 4-12% gradient gel is used for analysis. Lane 1. 0.8 µg Monoclonal antibody to Influenza A, clone 8F8 (-DTT) Lane 2. Size marker (Smobio) Lane 3. 0.8 µg Monoclonal antibody to Influenza A, clone 8F8 (+DTT).

      mAb to Influenza A, clone 8F8  

Figure 2. HPLC analytical SEC for final product.

      mAb to Influenza A, clone 8F8  

Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.

      mAb to Influenza A, clone 8F8  

Figure 4.Octet RED96e analysis, antibody was loaded on sensor for capture of H3N2 nucleocapsid protein.

  mAb to Influenza A, clone 8F8  

Figure 5. Octet RED96e analysis, antibody was loaded on sensor for capture of H1N1 nucleocapsid protein.

                 

Select volume:

Quantity:

Catalogue #

R1-190-100

Name

mAb to Influenza A, clone 8F8

Target

Recombinant Influenza A Nucleocapsid protein

Target Description

Produced by CHO-based Icosagen Cell Factory Ltd. proprietary suspension cell line

Uniprot ID

P03466

Source

Human

Clonality

Human monoclonal

Clone

8F8

Class

hIgG1

Dissociation constant (KD)

7.50 x 10-09 M (measured against Influenza A H1N1 nucleocapsid protein)
4.05 x 10-09 M (measured against Influenza A H3N2 nucleocapsid protein)

Application

ELISA

Purification

Protein A affinity chromatography following gel filtration

Buffer

PBS pH 7.4

QC

Simply Safe Stained SDS-PAGE, analytical SEC, Octet binding

Shipping

Shipped with blue ice.

Storage

Store at +4 °C. Divide antibody into aliquots prior usage.

This product is for research use only

TECHNICAL ASSISTANCE

Please refer any technical questions to

technical.support@icosagen.com

Our locations

United States Office

77 Geary St. 5th Floor
San Francisco, CA 94108
+1 415 548 6625

European Office

Eerika tee 1
Õssu, Kambja vald
Tartu maakond 61713
Estonia
+372 737 7070
Shopping Cart